AEON Biopharma, Inc. (AEON) — Long-term Investment Intensity
AEON Biopharma, Inc. (AEON) has a Long-term Investment Intensity of 1.2% as of December 2019. Long-term investments of $1.43 Million represent 1.2% of total assets of $114.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AEON Biopharma, Inc. liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AEON Biopharma, Inc. Long-term Investment Intensity (2019–2019)
This chart shows how AEON Biopharma, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the intensity stands at 1.2%, reflecting long-term investments of $1.43 Million against total assets of $114.35 Million USD. For the complete balance sheet picture, see AEON Biopharma, Inc. total assets.
Annual Long-term Investment Intensity for AEON Biopharma, Inc. (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for AEON Biopharma, Inc. from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read AEON total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.2% | $1.43 Million | $114.35 Million | — |